Literature DB >> 28104337

Pulmonary Embolism and Clozapine Use: A Case Report and Literature Review.

Rakesh K Gami1, Prakash Mishra2, Thomas Sedlak3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28104337     DOI： 10.1016/j.psym.2016.11.004

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  5 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

2.  Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies.

Authors:  Yinzhao Liu; Jun Xu; Kacey Fang; Yue Xu; Ju Gao; Chao Zhou; Xiaowei Tang; Xinyu Fang; Jiu Chen; Chunming Xie; Fuquan Zhang; Xiangrong Zhang; Congjie Wang
Journal:  Ther Adv Psychopharmacol       Date:  2021-01-14

3.  Clozapine-induced pulmonary embolism in a patient with no pre-existing risk factors: A case report.

Authors:  Jing Yi Kwan; Maha Noor
Journal:  Clin Case Rep       Date:  2022-03-18

4.  Pulmonary Embolism during a Retrial of Low-dose Clozapine.

Authors:  Gregg Alan Robbins-Welty; Shannon Coats; Andrew N Tuck; Bryan K Lao; Zachary Lane
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-08-31       Impact factor: 3.731

5.  Excited catatonia in a patient with fatal pulmonary embolism and a successful treatment strategy.

Authors:  Wei-Ting Tseng; Tiao-Lai Huang
Journal:  BMC Psychiatry       Date:  2018-10-19       Impact factor: 3.630
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.